Park Medi World Limited (PARKHOSPS)
Investor Presentation Q1 FY''27
AI summary
- Q1 FY27 revenue grew 19% YoY to ₹4,757 mn; EBITDA rose 20% YoY to ₹1,261 mn with 26.5% margin
- Net profit increased 35% YoY to ₹886 mn; net profit margin expanded 220 bps YoY to 18.6%
- Total bed capacity up 32% YoY to 3,960 beds; 46% capacity addition planned in calendar 2026
- Acquisitions include The Medicity Hospital Rudrapur (330 beds) and Mehar Hospital Zirakpur (150 beds)
- Capacity expected to reach 4,740 beds by FY27 end and 5,740 beds by March 2028
- Growth funded mainly through internal accruals and IPO proceeds, with no material fresh debt
- Focus on integrating acquisitions, improving utilization, and sustaining profitability
- Strong balance sheet with negative net debt and ₹2,998 mn in fixed deposits
- Expansion driven by cluster strategy, super-speciality capabilities, and high-acuity care
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 PARKHOSPS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add PARKHOSPS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Park Medi World Limited
Important.
The summary above is generated automatically from Park Medi World Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.